
CJC-No DAC / IPA Blend 5MG / 5MG
No COA is linked to this product yet. Check the COA page or contact support if a document should be available.
Open COA pageSelect your amount and quantity.
CJC-No DAC / IPA Blend 5MG / 5MG Research Overview
This blend combines CJC-1295 No DAC (Modified GRF 1–29) and Ipamorelin at 5 mg each — the most frequently referenced GHRH/secretagogue pairing in GH-axis research. CJC-No DAC / IPA Blend 5MG / 5MG is supplied for qualified in-vitro laboratory research and analytical use only.
Compound profile
- Compound class: Two-peptide GH-axis research blend
- Components: CJC-1295 No DAC (Mod GRF 1–29) and Ipamorelin
- Amounts: 5 mg / 5 mg per vial
- Form: Lyophilized multi-peptide blend in a sealed vial
- Testing: Third-party HPLC purity and identity, batch-matched COA
Research context
CJC-1295 No DAC activates the GHRH receptor, while Ipamorelin selectively activates the ghrelin receptor (GHS-R1a). Studying them together models the amplified, pulse-like growth-hormone release that results when both pathways are engaged. Both components are also stocked individually for single-compound controls.
Storage and handling
Store unopened lyophilized vials sealed and protected from light — at −20 °C for long-term storage, or 2–8 °C for short-term use. Once reconstituted, keep refrigerated at 2–8 °C, minimize freeze–thaw cycles and rely on your laboratory’s own validated stability data.
Quality and documentation
Every lot is third-party tested, and the Certificate of Analysis is matched to the exact batch you receive — look it up any time on the COA page. Browse more GH / IGF Axis Research, or see related compounds: CJC-1295 No DAC, IPA 10MG.
Research Use Only Notice: Not for human consumption, not for veterinary use, not for clinical or diagnostic use, and not intended as a drug, food, dietary supplement, cosmetic, or household product. Purchaser is responsible for confirming lawful use, handling requirements, and regulatory status before purchase or use.